Verrica Pharmaceuticals Inc (VRCA)

12:27 PM

Is Verrica Pharmaceuticals Inc. stock a good hedge against inflationOver 200% growth - jammulinksnews.com

12:27 PM

Jul 23, 2025

Verrica Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit velocity - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Verrica Pharmaceuticals Inc. stockSky-high return potential - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split By Investing.com - Investing.com South Africa

Jul 23, 2025

Jul 23, 2025

Verrica Pharmaceuticals Announces Reverse Stock Split - TipRanks

Jul 23, 2025

Jul 23, 2025

Verrica Pharmaceuticals to implement 1-for-10 reverse stock split - Investing.com

Jul 23, 2025

Jul 22, 2025

Is Verrica Pharmaceuticals Inc. a good long term investmentAccelerated earnings growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

What drives Verrica Pharmaceuticals Inc. stock priceFree Predictions - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

Published on: 2025-07-19 07:38:47 - jammulinksnews.com

Jul 19, 2025

Jul 18, 2025

Is Verrica Pharmaceuticals Inc. stock overhyped or has real potentialAnalyst Grade Signals - Newser

Jul 18, 2025

Jul 18, 2025

What institutions are buying Verrica Pharmaceuticals Inc. stock nowDaily Trade Opportunity - Newser

Jul 18, 2025

Jul 15, 2025

What makes Verrica Pharmaceuticals Inc. stock price move sharplyInsider Strategy Insight - Newser

Jul 15, 2025

Jul 15, 2025

Why Verrica Pharmaceuticals Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - newser.com

Jul 15, 2025

Jul 15, 2025

How Verrica Pharmaceuticals Inc. stock performs during market volatilityFree Stock Trading Community - Newser

Jul 15, 2025

Jul 14, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives $8.00 Average Target Price from Brokerages - Defense World

Jul 14, 2025

Jul 10, 2025

Verrica Reports Strong Q2 Growth as YCANTH Demand Accelerates - MyChesCo

Jul 10, 2025

Jul 10, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 - GlobeNewswire

Jul 10, 2025

Jul 10, 2025

Verrica Pharmaceuticals (NASDAQ:VRCA) Shares Down 4.9% – Should You Sell? - Defense World

Jul 10, 2025

Jul 10, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales By Investing.com - Investing.com South Africa

Jul 10, 2025

Jul 09, 2025

Verrica Pharmaceuticals Reports Strong Growth in YCANTH® Dispensed Applicator Units in 2Q 2025 | VRCA Stock News - GuruFocus

Jul 09, 2025

Jul 09, 2025

Verrica Pharmaceuticals reports 32.8% quarterly growth in YCANTH sales - Investing.com

Jul 09, 2025

Jul 02, 2025

Verrica Pharmaceuticals Advances Global Phase 3 Trial for YCANTH with Amended Torii Agreement - MyChesCo

Jul 02, 2025

Jul 01, 2025

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Commo - GuruFocus

Jul 01, 2025

Jul 01, 2025

Verrica Pharmaceuticals Receives Milestone Payments and Initiates Global Phase 3 Trial for YCANTH® Treatment of Common Warts - Quiver Quantitative

Jul 01, 2025

Jul 01, 2025

Verrica Pharmaceuticals Announces Amendment to Collaboration and License Agreement with Torii Pharmaceutical to Launch Global Pivotal Phase 3 Clinical Trial to Study YCANTH® for the Treatment of Common Warts - The Manila Times

Jul 01, 2025

Jun 18, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Sees Significant Decline in Short Interest - Defense World

Jun 18, 2025

Jun 18, 2025

Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results - Barchart.com

Jun 18, 2025

Jun 16, 2025

Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Given Average Recommendation of “Hold” by Brokerages - Defense World

Jun 16, 2025

Jun 13, 2025

Shareholders May Not Overlook Verrica Pharmaceuticals Insiders Selling US$1.1m In Stock - simplywall.st

Jun 13, 2025